BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Australia Approves First RNAi Therapy For Familial Chylomicronemia Syndrome

– REDEMPLO is the first and only medicine approved for use in the treatment of FCS in Australia, and is authorized for both genetically confirmed a...

May 05, 2026 | Report

Olympus Corporation Partners With EndoRobotics To Advance Global Access To Robot Assisted Endoscopic Care

Partnership Aimed at Expanding Patient Access to Advanced EndoTherapeutic Procedures Olympus Corporation (Olympus), a global MedTech company co...

May 05, 2026 | News

Olympus And Canon Medical Expand Advanced Endoscopic Ultrasound Capabilities With Aplio i800 EUS Launch

Olympus Corporation and Canon Medical Systems USA, Inc. announced the U.S. launch of the Aplio i800 EUS premium ultrasound system. Manufactured by Canon In...

May 04, 2026 | News

ACROBiosystems And SeromYx Partner To Advance Functional Profiling Of Anti CD20 Antibodies

ACROBiosystems, a company dedicated to being a cornerstone of the global biopharmaceutical and healthcare industries, has entered into a research collabora...

May 01, 2026 | News

IMG Pharmaceutical Co Ltd To Acquire Matsumoto Pharmaceutical Co Ltd To Strengthen Integrated Healthcare Platform

IMG Pharmaceutical Co., Ltd. ("IMG Pharma"), a majority-owned subsidiary of IMG Japan, the Group's holding company, announced that it has entered into a de...

April 29, 2026 | News

Cordis Launches SELUTION SLR Drug Eluting Balloon In Japan For Peripheral Artery Disease

Cordis, a global leader in interventional cardiovascular technologies, today announces the launch and availability of the SELUTION SLR™ PTA Drug...

April 29, 2026 | News

Kyowa Kirin Co., Ltd. And Kura Oncology, Inc. Advance Ziftomenib With Japan Phase 2 Trial In NPM1 Mutated AML

Regulatory Filing in Japan Planned Following Clinical Trial Completion – Kyowa Kirin Co., Ltd. (TSE: 4151, “Kyowa Kirin”) and Kura...

April 27, 2026 | News

Waters Secures IVDR CE Mark For BD BACTEC FXI System Advancing Faster Bloodstream Infection Diagnostics

Achieves a ~3‑hour faster time to detection (~15% reduction) versus the prior generation system, per clinical study data,¹ enabling earlier target...

April 20, 2026 | News

Toshiba Corporation Advances Quantum Inspired Computing With 100 Fold Faster Optimisation Algorithm

Toshiba Corporation has developed a breakthrough algorithm that dramatically boosts the performance of the Simulated Bifurcation Machine (SBM), its proprie...

April 08, 2026 | News

NJ Bio And Ajinomoto Bio-Pharma Services Collaborate To Expand AJICAP Access For ADC Development

NJ Bio, Inc. ("NJ Bio"), a leading provider of integrated drug discovery and development services and Ajinomoto Bio‑Pharma Services ("Aji Bio‑Pharma"),...

April 02, 2026 | News

Matricelf And CiRA Foundation Partner To Advance Scalable iPSC Based Neural Tissue Manufacturing

Matricelf Ltd. (TASE: MTLF), a biotechnology company developing a novel autologous engineered neural tissue therapy for patients with spinal cord injury, a...

March 31, 2026 | News

Eisai And Nuvation Bio Advance Taletrectinib With EMA Validation For ROS1 Positive Lung Cancer

Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”), a human-centered global leading research-based pharmaceutical company w...

March 30, 2026 | News

Fujitsu And Osaka University Advance Quantum Computing With STAR Architecture Ver 3

Fujitsu Limited and the Center for Quantum Information and Quantum Biology at The University of Osaka announced the development of a new technology...

March 26, 2026 | News

Yoshindo And Cytiva Strengthen Japan’s Biologics Sovereignty Through Scalable Modular Manufacturing

Strengthening Yoshindo’s domestic biosimilar manufacturing footprint Cytiva’s modular manufacturing platform to support Yoshindo wit...

March 25, 2026 | News

Stay Connected